- Service Name
Celltrion
- Industry
Biopharmaceuticals, Healthcare, Biotechnology, Biosimilars
- Main Value Proposition
Celltrion offers advanced and affordable biopharmaceutical products that are globally accessible, ensuring improved health outcomes for patients.
- Description
Celltrion is a leading biopharmaceutical company specializing in the research, development, manufacturing, and marketing of innovative therapeutics, particularly in the biosimilar space. The company aims to improve patient access to high-quality medicines globally.
- Key Features
One-stop solutions for biopharmaceutical business from R&D to distribution; First in Asia to operate US FDA cGMP certified animal cell culture facilities; Largest manufacturer and exporter of biosimilars in Korea; Global distribution network in over 100 countries
- Use Cases
Providing affordable treatment options for chronic diseases like rheumatoid arthritis and psoriasis; Expanding access to biosimilars in various global markets; Supporting healthcare systems with innovative drug solutions
- Competitive advantages
Strong R&D capabilities with a focus on innovative drug development; Established global distribution network enhancing market reach; Cost-effective solutions through a vertically integrated business model
- Strengths
Celltrion's strengths lie in its extensive experience in biopharmaceuticals, strong regulatory compliance, and a commitment to quality and innovation in drug development.
- Positioning
Celltrion positions itself as a leader in the biopharmaceutical industry, focusing on innovation and accessibility in drug development and distribution.
- Audience
The primary audience includes healthcare professionals, patients requiring biopharmaceutical treatments, and investors looking for growth in the biopharmaceutical sector.
- CTA
Read more
- Tags
Biosimilars
Biopharmaceuticals
Innovative Therapies
Global Health
- Tagline
Daring to Go Beyond
- Tone of Voice
Professional, informative, optimistic
- Differentiation
Celltrion is a pioneer in the biosimilar market, having launched the world's first monoclonal antibody biosimilar, and continues to innovate with a robust pipeline of novel therapeutics.
- Brand Positioning
Celltrion's brand identity emphasizes its commitment to improving patient lives through innovative and high-quality biopharmaceuticals, while maintaining a strong presence in the global market.
- Founded
2002-02-01
- Founders
Jung Jin Seo